Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension: insights from a single-centre study

Tokgöz, Hacer CerenKültürsay, B.Tanyeri, S.Hakgör, AykunKeskin, BengisuBuluş, Çağdaş2025-12-082025-12-082024Tokgöz, H. C., Kültürsay, B.,Tanyeri, S., Hakgör, A., Keskin, B. ve Buluş, Ç. (2024). Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension: insights from a single-centre study. European-Society-of-Cardiology Congress (ESC), 45, London, England, August 30-September 02, 2024. http://dx.doi.org/10.1093/eurheartj/ehae666.22330195-668X1522-9645http://dx.doi.org/10.1093/eurheartj/ehae666.2233https://hdl.handle.net/20.500.12511/13303...eninfo:eu-repo/semantics/openAccessCardiac & Cardiovascular SystemsCardiologyMeeting AbstractEfficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension: insights from a single-centre studyConference Object4510.1093/eurheartj/ehae666.2233Q1WOS:001372468900041